FLUPHENAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Risk for at least one adverse event per patient · patients with schizophrenia
FLUPHENAZINE showed no clear difference in adverse effects‐at least one adverse effect compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (moderate certainty).
1 finding from 1 review
- Fluphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 0.79 [0.58, 1.07]1 study · 65 participantsModerate